Cancer Prevention Pharmaceuticals, Inc.
3 clinical trials · Sponsor
◉ Watch Cancer Prevention Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Urinary Biomarker Study With Sulindac and Difluoromethylornithine (NCT01636128) | Cancer Prevention Pharmaceuticals, Inc. | 2014-03-01 |
| Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) (NCT01483144) | Cancer Prevention Pharmaceuticals, Inc. | 2013-10-01 |
| A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP) (NCT01245816) | Cancer Prevention Pharmaceuticals, Inc. | 2011-03-01 |
Track Cancer Prevention Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.